Obesity and Osteoarthritis

From a western clinical perspective, obesity and osteoarthritis (OA) share a robust, largely bidirectional relationship. Epidemiologic data show a clear dose–response between higher BMI and OA—most prominently at the knee—beginning at overweight and escalating with obesity and severe obesity. The knee, as a major load-bearing joint, experiences amplified compressive and shear forces with added body mass; malalignment and prior meniscal or ligament injury further magnify these loads and accelerate cartilage wear. Yet the story is not purely mechanical: associations between obesity and hand OA, along with biomarker evidence, point to a metabolic–inflammatory pathway. Adipose tissue acts as an endocrine organ, secreting adipokines (e.g., leptin) and cytokines (e.g., IL-6, TNF-α) that can drive synovitis and cartilage matrix degradation, potentially sensitizing joints to the effects of load. Therapeutically, guidelines place weight management and therapeutic exercise at the core of OA care. Randomized trials support that structured dietary programs combined with aerobic and strengthening exercise improve pain and function, with larger and more sustained benefits when weight loss reaches around 10% of body mass. Exercise confers benefits even without weight loss by enhancing shock absorption and neuromuscular control. Physical therapy, gait retraining, and bracing can reduce joint moments and symptomatic load, facilitating safe activity necessary to maintain weight loss. Pharmacologic tools for obesity have expanded: GLP-1–based agents produce substantial weight loss and, in recent trials, improved knee OA pain and function relative to placebo, though long-term structural effects remain under study. In selected patients, bariatric surgery induces large, durable weight loss with common improvements in joint pain and function; cohort data suggest possible reductions in future arthroplasty risk. Clinically, managing comorbidities (diabetes, hypertension, depression), addressing sleep and pain catastrophizing, and removing access barriers (transportation, cost, safe places to exercise) are integral to success. NSAIDs, intra-articular corticosteroid or hyaluronic acid injections, and ultimately arthroplasty remain symptom- or end-stage options, but do not address the metabolic drivers. Key research gaps include defining optimal weight-loss composition (diet vs. medication vs. surgery) for joint structure preservation, validating long-term joint outcomes with anti-obesity drugs, and personalizing programs based on biomechanical and inflammatory phenotypes.

Traditional and integrative frameworks see the obesity–osteoarthritis connection as a convergence of accumulation, obstruction, and weakness. In Traditional Chinese Medicine (TCM), obesity reflects ‘phlegm-damp’ and spleen qi deficiency, while OA (“bi syndrome”) arises when wind-cold-damp obstruct channels and collaterals, particularly where terrain is weakened. Excess body weight intensifies dampness and stagnation around joints, aggravating pain and stiffness. Ayurveda similarly describes kapha dominance and ama (undigested residues) as central to medoroga (obesity) and sandhivata (OA); impaired digestive fire (agni) yields heaviness, swelling, and joint discomfort. These models, while using different language, map onto modern concepts of low-grade inflammation, fluid retention, and reduced tissue resilience. Care emphasizes restoring flow and reducing accumulation through gentle, sustained movement, mindful nutrition, and therapies that modulate pain and inflammation. Tai chi, qigong, and yoga cultivate balance, breath, and joint-friendly strength, aligning with evidence for improved pain and function in knee OA and supporting weight control through consistent activity. Acupuncture is used to disperse obstruction and relieve pain; modern trials show modest but clinically meaningful benefits for chronic osteoarthritic pain. Herbal strategies—such as TCM formulas (e.g., Du Huo Ji Sheng Tang) or Ayurvedic botanicals like guggul and turmeric/curcumin—are selected to transform dampness/ama and ease pain; contemporary studies suggest potential symptom relief, though heterogeneity and quality limitations temper conclusions. Dietary guidance centers on lighter, warm, and spice-forward meals that reduce heaviness (damp/kapha), paralleling Mediterranean-style patterns that support weight management and may lower systemic inflammation. Heat therapies (moxibustion, warm compresses), topical liniments, and manual therapies can complement movement. Importantly, practitioners individualize care—considering constitution, digestion, sleep, and stress—and coordinate with biomedical treatments. Integrative research priorities include rigorous trials of combined mind–body, acupuncture, and nutritional protocols in people with obesity-related OA, and exploration of personalized approaches for phenotypes marked by prominent ‘dampness/ama’ or by mechanical malalignment.